4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001415889-18-000013
Director sold 25,000 shares at $30.06 ($751,543)
- Director acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Brege Laura Director | 2018-01-02 | Option exercise | +15,000 | $8.06 | $120,900 | 15,000 | D |
| Brege Laura Director | 2018-01-02 | Option exercise | +10,000 | $8.49 | $84,900 | 25,000 | D |
| Brege Laura Director | 2018-01-02 | Sale | −25,000 | $30.06 | $751,543 | 0 | D |
| Derivatives | |||||||
| Brege Laura Director | 2018-01-02 | Option exercise · Stock option (right to buy) | −15,000 | 0 | D | ||
| Brege Laura Director | 2018-01-02 | Option exercise · Stock option (right to buy) | −10,000 | 0 | D | ||
| Open-market sales · 25,000 sh · avg $30.06 · $751,543 | |||||||
Loading xslF345X03/form4-01042018_030120.xml…